Cochrane · systematic review · CD009002

Omega‐3 fatty acids for the treatment of dementia

Burckhardt, M, Herke, M, Wustmann, T, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
11
No studies
1
Included studies
NR
No studies 1 · 8.3%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 3 · 25%High 8 · 66.7%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Omega‐3 PUFA supplements compared to placebo for people with mild to moderate Alzheimer's disease

Population: people with mild to moderate Alzheimer's disease
12 questions
OutcomeEffectEvidenceStatus / GRADE
Any adverse event (combined: diarrhoea, urinary tract infection, falls, dizziness, agitations)
Omega‐3 PUFA supplements vs placebo
RR 1.02 [0.95, 1.1]1 study · 402 participantsModerate
Downgraded: risk of bias
Serious adverse events "Defined as events that result in death, hospitalization, prolongation of hospitalization, or are life threatening (based on the judgment of the study physician)" (Quinn 2010)
Omega‐3 PUFA supplements vs placebo
RR 1.05 [0.78, 1.41]1 study · 402 participantsHigh
QoL
Omega‐3 PUFA supplements vs placebo
no estimate extracted1 study · 269 participantsModerate
Downgraded: risk of bias, imprecision
QoL
Omega‐3 PUFA supplements vs placebo
no estimate extracted1 study · 332 participantsHigh
Mental health (depression)
Omega‐3 PUFA supplements vs placebo
no estimate extracted1 study · 178 participantsHigh
Mental health
Omega‐3 PUFA supplements vs placebo
no estimate extracted2 studies · 543 participantsHigh
Global cognitive function
Omega‐3 PUFA supplements vs placebo
no estimate extracted3 studies · 566 participantsHigh
Global cognitive function
Omega‐3 PUFA supplements vs placebo
no estimate extracted2 studies · 202 participantsHigh
IADL
Omega‐3 PUFA supplements vs placebo
no estimate extracted1 study · 22 participantsModerate
Downgraded: risk of bias, imprecision
ADL
Omega‐3 PUFA supplements vs placebo
no estimate extracted2 studies · 544 participantsHigh
Overall dementia severity (cognition and function combined)
Omega‐3 PUFA supplements vs placebo
no estimate extracted2 studies · 542 participantsHigh
Memory ‐ not measured
Omega‐3 PUFA supplements vs placebo
no estimate extractedNRNo studies